Mitochondria and Epigenetics – Crosstalk in Homeostasis and Stress

Trends in Cell Biology

Volumn 27, Issue 6, 2017, Pages 453-463

  Matilainen, Olli ^a   Quirós, Pedro M ^a   Auwerx, Johan ^a  

^a EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA;

CHROMATIN; DNA METHYLATION; EPIGENETICS; HISTONE METHYLATION; HOMEOSTASIS; HUMAN; INVERTEBRATE; LIFE EXTENSION; LIFESPAN; MITOCHONDRIAL GENETICS; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRESS; UNFOLDED PROTEIN RESPONSE; YEAST; ANIMAL; GENETIC EPIGENESIS; GENETICS; METABOLISM; PHYSIOLOGICAL STRESS;

ANIMALS; CHROMATIN; DNA METHYLATION; DNA, MITOCHONDRIAL; EPIGENESIS, GENETIC; HOMEOSTASIS; HUMANS; MITOCHONDRIA; STRESS, PHYSIOLOGICAL;

EID: 85014136005     PISSN: 09628924     EISSN: 18793088     Source Type: Journal    
DOI: 10.1016/j.tcb.2017.02.004     Document Type: Review

References (93)

1. Nunnari, J., Suomalainen, A., Mitochondria: in sickness and in health. Cell 148 (2012), 1145–1159.
2. Wallace, D.C., Chalkia, D., Mitochondrial DNA genetics and the heteroplasmy conundrum in evolution and disease. Cold Spring Harbor Perspect. Biol., 5, 2013, a021220.
3. Rebelo, A.P., et al. Mitochondrial DNA transcription regulation and nucleoid organization. J. Inherit. Metab. Dis. 34 (2011), 941–951.
4. Couvillion, M.T., et al. Synchronized mitochondrial and cytosolic translation programs. Nature 533 (2016), 499–503.
5. Richter-Dennerlein, R., Mitochondrial protein synthesis adapts to influx of nuclear-encoded protein. Cell 167 (2016), 471–483.
6. Quiros, P.M., et al. Mitonuclear communication in homeostasis and stress. Nat. Rev. Mol. Cell Biol. 17 (2016), 213–226.
7. Margueron, R., Reinberg, D., Chromatin structure and the inheritance of epigenetic information. Nat. Rev. Genet. 11 (2010), 285–296.
8. Zentner, G.E., Henikoff, S., Regulation of nucleosome dynamics by histone modifications. Nat. Struct. Mol. Biol. 20 (2013), 259–266.
9. Allis, C.D., Jenuwein, T., The molecular hallmarks of epigenetic control. Nat. Rev. Genet. 17 (2016), 487–500.
10. Teperino, R., et al. Histone methyl transferases and demethylases; can they link metabolism and transcription?. Cell Metab. 12 (2010), 321–327.
11. Mouchiroud, L., et al. Transcriptional coregulators: fine-tuning metabolism. Cell Metab. 20 (2014), 26–40.
12. Menzies, K.J., et al. Protein acetylation in metabolism–metabolites and cofactors. Nat. Rev. Endocrinol. 12 (2016), 43–60.
13. Tessarz, P., Kouzarides, T., Histone core modifications regulating nucleosome structure and dynamics. Nat. Rev. Mol. Cell Biol. 15 (2014), 703–708.
14. Seto, E., Yoshida, M., Erasers of histone acetylation: the histone deacetylase enzymes. Cold Spring Harbor Perspect. Biol., 6, 2014, a018713.
15. Lee, K.K., Workman, J.L., Histone acetyltransferase complexes: one size doesn't fit all. Nat. Rev. Mol. Cell Biol. 8 (2007), 284–295.
16. Pietrocola, F., et al. Acetyl coenzyme A: a central metabolite and second messenger. Cell Metab. 21 (2015), 805–821.
17. Wellen, K.E., et al. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324 (2009), 1076–1080.
18. Martinez-Reyes, I., TCA cycle and mitochondrial membrane potential are necessary for diverse biological functions. Mol. Cell 61 (2016), 199–209.
19. + and sirtuin-activating compounds. Nat. Rev. Mol. Cell Biol. 17 (2016), 679–690.
20. Houtkooper, R.H., et al. Sirtuins as regulators of metabolism and healthspan. Nat. Rev. Mol. Cell Biol. 13 (2012), 225–238.
21. Chalkiadaki, A., Guarente, L., The multifaceted functions of sirtuins in cancer. Nat. Rev. Cancer 15 (2015), 608–624.
22. German, N.J., Haigis, M.C., Sirtuins and the metabolic hurdles in cancer. Current biology 25 (2015), R569–583.
23. Imai, S., et al. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403 (2000), 795–800.
24. Greer, E.L., Shi, Y., Histone methylation: a dynamic mark in health, disease and inheritance. Nat. Rev. Genet. 13 (2012), 343–357.
25. Voigt, P., et al. A double take on bivalent promoters. Genes Dev. 27 (2013), 1318–1338.
26. Chiang, P.K., et al. S-adenosylmethionine and methylation. FASEB J. 10 (1996), 471–480.
27. Ducker, G.S., Rabinowitz, J.D., One-carbon metabolism in health and disease. Cell Metab. 25 (2017), 27–42.
28. He, S., et al. Lysine methyltransferase SETD7 (SET7/9) regulates ROS signaling through mitochondria and NFE2L2/ARE pathway. Sci. Rep., 5, 2015, 14368.
29. Shi, Y., et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119 (2004), 941–953.
30. Metzger, E., et al. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 437 (2005), 436–439.
31. Wang, Y., et al. LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer. Cell 138 (2009), 660–672.
32. Lee, M.G., et al. An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation. Nature 437 (2005), 432–435.
33. Perillo, B., et al. DNA oxidation as triggered by H3K9me2 demethylation drives estrogen-induced gene expression. Science 319 (2008), 202–206.
34. Duteil, D., et al. LSD1 promotes oxidative metabolism of white adipose tissue. Nat. Commun., 5, 2014, 4093.
35. Hino, S., et al. FAD-dependent lysine-specific demethylase-1 regulates cellular energy expenditure. Nat. Commun., 3, 2012, 758.
36. Zeng, X., et al. Lysine-specific demethylase 1 promotes brown adipose tissue thermogenesis via repressing glucocorticoid activation. Genes Dev. 30 (2016), 1822–1836.
37. Sambeat, A., et al. LSD1 interacts with Zfp516 to promote UCP1 transcription and brown fat program. Cell Rep. 15 (2016), 2536–2549.
38. Duteil, D., et al. Lsd1 ablation triggers metabolic reprogramming of brown adipose tissue. Cell Rep. 17 (2016), 1008–1021.
39. Sakamoto, A., et al. Lysine demethylase LSD1 coordinates glycolytic and mitochondrial metabolism in hepatocellular carcinoma cells. Cancer Res. 75 (2015), 1445–1456.
40. Kooistra, S.M., Helin, K., Molecular mechanisms and potential functions of histone demethylases. Nat. Rev. Mol Cell Biol. 13 (2012), 297–311.
41. Xiao, M., et al. Inhibition of alpha-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev. 26 (2012), 1326–1338.
42. Liu, X., Secombe, J., The histone demethylase KDM5 activates gene expression by recognizing chromatin context through its PHD reader motif. Cell Rep. 13 (2015), 2219–2231.
43. Varaljai, R., et al. Increased mitochondrial function downstream from KDM5A histone demethylase rescues differentiation in pRB-deficient cells. Genes Dev. 29 (2015), 1817–1834.
44. Lopez-Bigas, N., et al. Genome-wide analysis of the H3K4 histone demethylase RBP2 reveals a transcriptional program controlling differentiation. Mol. Cell 31 (2008), 520–530.
45. Sullivan, L.B., et al. The proto-oncometabolite fumarate binds glutathione to amplify ROS-dependent signaling. Mol. Cell 51 (2013), 236–248.
46. Sciacovelli, M., et al. Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition. Nature 537 (2016), 544–547.
47. Cervera, A.M., et al. Inhibition of succinate dehydrogenase dysregulates histone modification in mammalian cells. Mol. Cancer, 8, 2009, 89.
48. Tanaka, Y., et al. JmjC enzyme KDM2A is a regulator of rRNA transcription in response to starvation. EMBO J. 29 (2010), 1510–1522.
49. Yan, H., et al. IDH1 and IDH2 mutations in gliomas. New Eng. J. Med. 360 (2009), 765–773.
50. Figueroa, M.E., et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 18 (2010), 553–567.
51. Hancock, R.L., et al. Epigenetic regulation by histone demethylases in hypoxia. Epigenomics 7 (2015), 791–811.
52. Greer, E.L., et al. DNA methylation on N6-adenine in C elegans. Cell 161 (2015), 868–878.
53. 6-adenine in mammalian embryonic stem cells. Nature 532 (2016), 329–333.
54. Bergman, Y., Cedar, H., DNA methylation dynamics in health and disease. Nat. Struct. Mol. Biol. 20 (2013), 274–281.
55. Horvath, S., DNA methylation age of human tissues and cell types. Genome Biol., 14, 2013, R115.
56. Patil, V., et al. The evidence for functional non-CpG methylation in mammalian cells. Epigenetics 9 (2014), 823–828.
57. Schubeler, D., Function and information content of DNA methylation. Nature 517 (2015), 321–326.
58. Irvin, M.R., et al. Epigenome-wide association study of fasting blood lipids in the genetics of lipid-lowering drugs and diet network study. Circulation 130 (2014), 565–572.
59. Oh, S.Y., et al. Alternative usages of multiple promoters of the acetyl-CoA carboxylase beta gene are related to differential transcriptional regulation in human and rodent tissues. J. Biol. Chem. 280 (2005), 5909–5916.
60. Shore, A., et al. Role of Ucp1 enhancer methylation and chromatin remodelling in the control of Ucp1 expression in murine adipose tissue. Diabetologia 53 (2010), 1164–1173.
61. Kiskinis, E., et al. RIP140 directs histone and DNA methylation to silence Ucp1 expression in white adipocytes. EMBO J. 26 (2007), 4831–4840.
62. Barres, R., et al. Weight loss after gastric bypass surgery in human obesity remodels promoter methylation. Cell Rep. 3 (2013), 1020–1027.
63. Barres, R., et al. Acute exercise remodels promoter methylation in human skeletal muscle. Cell Metab. 15 (2012), 405–411.
64. Barres, R., et al. Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. Cell Metab. 10 (2009), 189–198.
65. Pastor, W.A., et al. TETonic shift: biological roles of TET proteins in DNA demethylation and transcription. Nat. Rev. Mol. Cell Biol. 14 (2013), 341–356.
66. Xu, W., et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases. Cancer Cell 19 (2011), 17–30.
67. Letouze, E., et al. SDH mutations establish a hypermethylator phenotype in paraganglioma. Cancer cell 23 (2013), 739–752.
68. Mason, E.F., Hornick, J.L., Succinate dehydrogenase deficiency is associated with decreased 5-hydroxymethylcytosine production in gastrointestinal stromal tumors: implications for mechanisms of tumorigenesis. Modern Pathol. 26 (2013), 1492–1497.
69. Gilkerson, R., et al. The mitochondrial nucleoid: integrating mitochondrial DNA into cellular homeostasis. Cold Spring Harbor Perspect. Biol., 5, 2013, a011080.
70. Bogenhagen, D.F., et al. The layered structure of human mitochondrial DNA nucleoids. J. Biol. Chem. 283 (2008), 3665–3675.
71. Lu, B., et al. Roles for the human ATP-dependent Lon protease in mitochondrial DNA maintenance. J. Biol. Chem. 282 (2007), 17363–17374.
72. Kukat, C., et al. Cross-strand binding of TFAM to a single mtDNA molecule forms the mitochondrial nucleoid. Proc. Natl. Acad. Sci. U.S.A. 112 (2015), 11288–11293.
73. Groot, G.S., Kroon, A.M., Mitochondrial DNA from various organisms does not contain internally methylated cytosine in -CCGG- sequences. Biochim. Biophys. Acta 564 (1979), 355–357.
74. Dawid, I.B., 5-methylcytidylic acid: absence from mitochondrial DNA of frogs and HeLa cells. Science 184 (1974), 80–81.
75. Vanyushin, B.F., Kirnos, M.D., Structure of animal mitochondrial DNA (base composition, pyrimidine clusters, character of methylation). Biochim. Biophys. Acta 475 (1977), 323–336.
76. Nass, M.M., Differential methylation of mitochondrial and nuclear DNA in cultured mouse, hamster and virus-transformed hamster cells. In vivo and in vitro methylation. J. Mol. Biol. 80 (1973), 155–175.
77. van der Wijst, M.G., Rots, M.G., Mitochondrial epigenetics: an overlooked layer of regulation?. Trends Genet. 31 (2015), 353–356.
78. Shock, L.S., et al. DNA methyltransferase 1, cytosine methylation, and cytosine hydroxymethylation in mammalian mitochondria. Proc. Natl. Acad. Sci. U.S.A. 108 (2011), 3630–3635.
79. Dzitoyeva, S., et al. Effect of aging on 5-hydroxymethylcytosine in brain mitochondria. Neurobiol. Aging 33 (2012), 2881–2891.
80. Iacobazzi, V., et al. Mitochondrial DNA methylation as a next-generation biomarker and diagnostic tool. Mol. Genet. Metab. 110 (2013), 25–34.
81. Houtkooper, R.H., et al. Mitonuclear protein imbalance as a conserved longevity mechanism. Nature 497 (2013), 451–457.
82. Dillin, A., et al. Rates of behavior and aging specified by mitochondrial function during development. Science 298 (2002), 2398–2401.
83. Durieux, J., et al. The cell-non-autonomous nature of electron transport chain-mediated longevity. Cell 144 (2011), 79–91.
84. Haynes, C.M., et al. The matrix peptide exporter HAF-1 signals a mitochondrial UPR by activating the transcription factor ZC376.7 in C. elegans. Mol. cell 37 (2010), 529–540.
85. Nargund, A.M., et al. Mitochondrial import efficiency of ATFS-1 regulates mitochondrial UPR activation. Science 337 (2012), 587–590.
86. Benedetti, C., et al. Ubiquitin-like protein 5 positively regulates chaperone gene expression in the mitochondrial unfolded protein response. Genetics 174 (2006), 229–239.
87. Haynes, C.M., et al. ClpP mediates activation of a mitochondrial unfolded protein response in C elegans. Dev. cell 13 (2007), 467–480.
88. Rea, S.L., et al. Relationship between mitochondrial electron transport chain dysfunction, development, and life extension in Caenorhabditis elegans. PLoS Biol., 5, 2007, e259.
89. Tian, Y., et al. Mitochondrial stress induces chromatin reorganization to promote longevity and UPR(mt). Cell 165 (2016), 1197–1208.
90. Merkwirth, C., et al. Two conserved histone demethylases regulate mitochondrial stress-induced longevity. Cell 165 (2016), 1209–1223.
91. Labbadia, J., Morimoto, R.I., Repression of the heat shock response is a programmed event at the onset of reproduction. Mol. cell 59 (2015), 639–650.
92. Schroeder, E.A., et al. Epigenetic silencing mediates mitochondria stress-induced longevity. Cell Metab. 17 (2013), 954–964.
93. Lopez-Otin, C., et al. The hallmarks of aging. Cell 153 (2013), 1194–1217.